MiMedx Group (NASDAQ:MDXG) Announces Earnings Results

MiMedx Group (NASDAQ:MDXG) announced its earnings results on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.07, Zacks reports. MiMedx Group had a return on equity of 26.21% and a net margin of 23.86%.

MiMedx Group Stock Performance

MDXG traded up $0.05 during midday trading on Wednesday, reaching $8.01. The company had a trading volume of 562,154 shares, compared to its average volume of 563,991. MiMedx Group has a 1 year low of $5.47 and a 1 year high of $10.14. The company has a quick ratio of 3.53, a current ratio of 4.10 and a debt-to-equity ratio of 0.10. The company has a market cap of $1.18 billion, a P/E ratio of 14.56 and a beta of 1.94. The business has a 50-day moving average of $8.78 and a two-hundred day moving average of $7.68.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a research note on Friday, November 8th. Six analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $12.00.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.